IIM
LAB icon

INTECH Investment Management’s Standard BioTools LAB Stock Holding History

INTECH Investment Management’s Portfolio LAB Stock Details LAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-63,430
Closed -$58.3K – 2204
2026
Q1 		$58.3K Sell
63,430
-58,334
-48% -$70.6K ﹤0.01% 1989
2025
Q4 		$156K Sell
121,764
-14,377
-11% -$19.3K ﹤0.01% 2057
2025
Q3 		$177K Sell
136,141
-12,877
-9% -$16.9K ﹤0.01% 2110
2025
Q2 		$179K Buy
149,018
+8,519
+6% +$9.44K ﹤0.01% 2129
2025
Q1 		$152K Buy
140,499
+32,491
+30% +$45.6K ﹤0.01% 2190
2024
Q4 		$189K Buy
108,008
+55,783
+107% +$104K ﹤0.01% 2053
2024
Q3 		$101K Buy
+52,225
New +$102K ﹤0.01% 1879

Other funds holding LAB

CC
Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
MCO
MAK Capital One New York $714M AUM 68.07% 1-Year Est. Return
LFCM
Long Focus Capital Management San Juan, Puerto Rico $3.91B AUM 12.68% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
HBWM
Hollow Brook Wealth Management Katonah, New York $504M AUM 26.89% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return
RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return

INTECH Investment Management's LAB Position: Q2 2026 in Review

INTECH Investment Management sold out of Standard BioTools (LAB) in Q2 2026, closing a stake of 63,430 shares — an estimated $58.3K sold.

INTECH Investment Management first reported a position in LAB in Q3 2024 and held it in 7 quarters. The position peaked at $189K in Q4 2024. 143 funds tracked by Wall St. Rank hold LAB as of Q2 2026.

  • INTECH Investment Management reported no remaining Standard BioTools position as of Q2 2026 after selling out during the quarter.
  • INTECH Investment Management sold 63,430 Standard BioTools shares in Q2 2026, an estimated $58.3K.
  • INTECH Investment Management first reported a position in Standard BioTools in Q3 2024 and held it in 7 quarters.
  • INTECH Investment Management's Standard BioTools position peaked at $189K in Q4 2024.
  • 143 funds tracked by Wall St. Rank held Standard BioTools as of Q2 2026.

Based on INTECH Investment Management's 13F filing for Q2 2026, filed 10 Aug 2026.